ICUI Stock Analysis: Buy, Sell, or Hold?
ICUI - ICU Medical Inc
$168.51
0.13 (0.08%)
▲
5d:
+7.03%
30d:
+13.51%
90d:
+41.37%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
2d
Get Alerted When ICUI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ICUI shows positive signals but monitor for confirmation. Market pricing in 4.1% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ICUI shows positive signals but monitor for confirmation. Market pricing in 4.1% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$230.75
Based on 9.2% avg growth
INTRINSIC VALUE TODAY
$143.28
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICUI is currently trading at $168.51, which is considered extended relative to its 30-day fair value range of $150.72 to $162.86. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.1) compared to its historical average (16.0). At these levels, the market is pricing in 4.1% annual earnings growth.
Technical Outlook: Technically, ICUI is in a strong uptrend. The price is approaching resistance at $170.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ICUI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICUI is in a strong uptrend. The price is approaching resistance at $170.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ICUI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$150.72 -
$162.86
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($176.62)
- BULLISH: Expecting earnings turnaround to 4.1% growth with -12.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$150.72 -
$162.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$152.71
Resistance Level
$170.81
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.05
Wall Street Target
$176.63
(+4.8%)
Revenue Growth (YoY)
-12.3%
Earnings Growth (YoY)
-23.8%
Profit Margin
2.1%
Valuation Premium vs History
+4.1% premium
PE vs Historical
18.1 vs 16.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$175.42
(+4%)
2-Year Target
$182.61
(+8%)
3-Year Target
$190.10
(+13%)
3-Yr Target (if PE normalizes)
(PE: 18→16)
PE COMPRESSION
$168.49
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 14.3%)
$289.19
(+72%)
Base:
(SPY PE: 18.1, Growth: 14.3%)
$251.83
(+49%)
Bear:
(PE: 15.3, Growth: 14.3%)
$214.05
(+27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Forward PE: 20.41 | Forward EPS (Implied): $8.26
Bull Case
$203.48
(+21%)
Analyst growth 15.0%, PE expands to 21.4
Base Case
$168.51
(0%)
Market implied 0.0%, PE stable at 20.4
Bear Case
$128.91
(-24%)
Severe decline -15.0%, PE contracts to 18.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 03, 2026 12:41 AM ET
Data refreshes hourly during market hours. Next update: 1:41 AM
Data refreshes hourly during market hours. Next update: 1:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICUI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$477 | 47 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$87 | 50 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 50 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 56 HOLD |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$15 | 56 HOLD |
